Studies on pharmacological effects and chemical components of different extracts from Bawei Chenxiang Pills.
10.19540/j.cnki.cjcmm.20250313.303
- Author:
Jia-Tong WANG
1
;
Lu-Lu KANG
1
;
Feng ZHOU
2
;
Luo-Bu GESANG
2
;
Ya-Na LIANG
1
;
Guo-Dong YANG
1
;
Xiao-Li GAO
1
;
Hui-Chao WU
3
;
Xing-Yun CHAI
1
Author Information
1. Modern Research Center of Chinese Medicine,Beijing Academy of Traditional Chinese Medicine,Beijing University of Chinese Medicine Beijing 102488,China.
2. Tibet Ganlu Pharmaceutical Technology Limited Liability Company Lhasa 850000,China.
3. Institute of Ethnic Medicine,School of Chinese Medicine,Beijing University of Chinese Medicine Beijing 102488,China.
- Publication Type:Journal Article
- Keywords:
Bawei Chenxiang Pills;
anti-myocardial ischemia;
hypnosis;
pharmacodynamic substance
- MeSH:
Animals;
Drugs, Chinese Herbal/isolation & purification*;
Mice;
Male;
Sleep Initiation and Maintenance Disorders/physiopathology*;
Humans;
Myocardial Infarction/drug therapy*;
Myocardial Ischemia/drug therapy*
- From:
China Journal of Chinese Materia Medica
2025;50(11):3035-3042
- CountryChina
- Language:Chinese
-
Abstract:
The medicinal materials of Bawei Chenxiang Pills(BCPs) were extracted via three methods: reflux extraction by water, reflux extraction by 70% ethanol, and extraction by pure water following reflux extraction by 70% ethanol, yielding three extracts of ST, CT, and CST. The efficacy of ST(760 mg·kg~(-1)), CT(620 mg·kg~(-1)), and CST(1 040 mg·kg~(-1)) were evaluated by acute myocardial ischemia(AMI) and p-chlorophenylalanine(PCPA)-induced insomnia in mice, respectively. Western blot was further utilized to investigate their hypnosis mechanisms. The main chemical components of different extracts were identified by the UPLC-Q-Exactive-MS technique. The results showed that CT and CST significantly increased the ejection fraction(EF) and fractional shortening(FS) of myocardial infarction mice, reduced left ventricular internal dimension at end-diastole(LVIDd) and left ventricular internal dimension at end-systole(LVIDs). In contrast, ST did not exhibit significant effects on these parameters. In the insomnia model, CT significantly reduced sleep latency and prolonged sleep duration, whereas ST only prolonged sleep duration without shortening sleep latency. CST showed no significant effects on either sleep latency or sleep duration. Additionally, both CT and ST upregulated glutamic acid decarboxylase 67(GAD67) protein expression in brain tissue. A total of 15 main chemical components were identified from CT, including 2-(2-phenylethyl) chromone and 6-methoxy-2-(2-phenylethyl) chromone. Six chemical components including chebulidic acid were identified from ST. The results suggested that chromones and terpenes were potential anti-myocardial ischemia drugs of BCPs, and tannin and phenolic acids were potential hypnosis drugs. This study enriches the pharmacological and chemical research of BCPs, providing a basis and reference for their secondary development, quality standard improvement, and clinical application.
